ALDX•benzinga•
Aldeyra Therapeutics To Announce Topline Results From Phase 3 Dry Eye Disease Clinical Trials Of Reproxalap At Conference Call Scheduled On May 6, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 5, 2025 by benzinga